活性氧响应型抗肿瘤前药研究进展

活性氧（ROS）在机体信号转导和代谢中起着至关重要的作用,而ROS水平的升高与多种病变（癌症和炎症等）息息相关,基于肿瘤组织高水平ROS开发的肿瘤特异杀伤性前药策略,在增强药效和药物选择性方面提供了一种新颖的方法.本综述介绍了目前用于构建抗肿瘤前药的ROS敏感键：芳基硼酸/酯、烷基硫/硒醚、硫缩酮、过氧草酸酯、氨基丙烯酸酯、噻唑烷酮和α-酮酰胺等,并且详叙了基于这些敏感键设计的前药在抗肿瘤方向上的应用,同时探讨了现有ROS响应型前药系统的研究进展和局限性,并对未来的研究方向进行了展望.     

Tapered copolymers of styrene and 4-vinylbenzocyclobutene via carbanionic polymerization for crosslinkable polymer films

Well-defined polystyrene homopolymers with surface-adhesive triethoxysilyl end group were synthesized via living carbanionic polymerization, epoxide end-functionalization and subsequent hydrosilylation with triethoxysilane. Grafting-to performance of polymers with various molecular weight (M_n = 3000–14,000 g mol⁻¹) to a silicon surface was examined in dependence of reaction time, polymer concentration, solvent and number of alkoxysilyl end groups. Crosslinkable polymers for surface modification were synthesized by statistical carbanionic copolymerization of 4-vinylbenzocyclobutene (4-VBCB) and styrene, followed by epoxide end-functionalization and triethoxysilane modification (M_n = 4000–14,000 g mol⁻¹). The copolymers were characterized by ¹H-NMR, THF-SEC, and matrix-assisted laser desorption and ionization time-of-flight mass spectrometry. In situ ¹H-NMR kinetic studies in cyclohexane-d₁₂ provided information regarding the monomer gradient in the polymer chains, with styrene being the more reactive monomer (r_s = 2.75, r_4-VBCB = 0.23). Thin polymer films on silicon wafers were prepared by grafting-to surface modification under conditions derived for the polystyrene homopolymer. The traceless, thermally induced crosslinking reaction of the benzocyclobutene units was studied by DSC in bulk as well as in 3–6 nm thick polymer films. Crosslinked films were analyzed by atomic force microscopy, ellipsometry, and nanoindentation, showing smooth polymer films with an increased modulus. © 2019 The Authors. Journal of Polymer Science published by Wiley Periodicals, Inc. J. Polym. Sci. 2020 , 58, 181–192     

A Microfluidic Co-Flow Route for Human Serum Albumin-Drug–Nanoparticle Assembly

Nanoparticles are widely studied as carrier vehicles in biological systems because their size readily allows access through cellular membranes. Moreover, they have the potential to carry cargo molecules and as such, these factors make them especially attractive for intravenous drug delivery purposes. Interest in protein-based nanoparticles has recently gained attraction due to particle biocompatibility and lack of toxicity. However, the production of homogeneous protein nanoparticles with high encapsulation efficiencies, without the need for additional cross-linking or further engineering of the molecule, remains challenging. Herein, we present a microfluidic 3D co-flow device to generate human serum albumin/celastrol nanoparticles by co-flowing an aqueous protein solution with celastrol in ethanol. This microscale co-flow method resulted in the formation of nanoparticles with a homogeneous size distribution and an average size, which could be tuned from ≈100 nm to 1 μm by modulating the flow rates used. We show that the high stability of the particles stems from the covalent cross-linking of the naturally present cysteine residues within the particles formed during the assembly step. By choosing optimal flow rates during synthesis an encapsulation efficiency of 75±24 % was achieved. Finally, we show that this approach achieves significantly enhanced solubility of celastrol in the aqueous phase and, crucially, reduced cellular toxicity.     

Evaluation of Pd→B Interactions in Diphosphinoborane Complexes and Impact on Inner-Sphere Reductive Elimination

The dative Pd→B interaction in a series of ^RDPB^R’ Pd⁰ and Pd^II complexes (^RDPB^R’=(o-PR₂C₆H₄)₂BR’, diphosphinoborane) was analyzed using XRD, ¹¹B NMR spectroscopy and NBO/NLMO calculations. The borane acceptor discriminates between the oxidation state Pd^II and Pd⁰, stabilizing the latter. Reaction of lithium amides with [(^RDPB^R’)Pd^II(4-NO₂C₆H₄)I] chemoselectively yields the C−N coupling product. DFT modelling indicates no significant impact of Pd^II→B coordination on the inner-sphere reductive elimination rate.     

基于毛细管电泳的天然产物中酶抑制剂筛选研究进展

人类疾病的发生往往与体内各种酶的功能失调密切相关,因此酶一直是目前新药研发的重要靶标。天然产物是发现新药的宝贵资源,但是由于成分复杂,活性筛选一直受制于耗时费力的分离纯化过程。毛细管电泳（CE）技术由于具有样品和试剂消耗少、灵活多样的分离模式且不受样品基质干扰的特点,可以直接从粗提物开始筛选活性成分,在复杂样品活性筛选中显示出独特的优势。该文综述了近十年来CE在天然产物中酶抑制剂筛选的研究进展。其中重点介绍了CE应用于重要药物靶标,包括转移酶（激酶）、水解酶以及氧化还原酶等方面的应用,总结了用于酶抑制剂筛选的电泳分离模式和酶动力学研究,并展望了CE用于天然产物中活性成分筛选的应用前景。     

Intriguing generative metabolism discovery of reactive metabolite nitroso of lapatinib and relevant structural modification

Lapatinib is required as a therapy for advanced or metastatic breast cancer. However, its reactive metabolite (RM) nitroso was implicated in idiosyncratic hepatotoxicity. Density functional theory was performed to explore the metabolism of nitroso formation. Primary hydroxylation amine is a critical intermediate to produce nitroso. Three pathways from secondary alkylamine lapatinib to primary hydroxylation amine were designed and discussed. Calculation results show that it is difficult to form primary hydroxylation amine through common proposed hydrolysis nitrone with a barrier of 36.67 kcal/mol (path A), but it is smoothly formed by paths B and C with moderate determined barriers of 15.09 kcal/mol and 16.56 kcal/mol, respectively. Subsequently, we demonstrate that the mechanism of nitroso formation from primary hydroxylation amine should be a double hydrogen atom transfer rather than the previously proposed hydrolysis primary dihydroxylation amine. The barrier of the former is obviously lower than the latter. Based on metabolism results and structure analysis, several lapatinib derivatives are designed. Molecular docking of designed compounds with epidermal growth factor receptor (EGFR) shows that they share a similar binding mode with lapatinib. In particular, 2a to 2d show similar binding energy to lapatinib. This work showed metabolism details of nitroso formation from lapatinib and its structure modification, which can enrich the metabolism of amine drugs and provide guidance for drug optimization and design.     

Hydrolysis of HNSO2: A potential route for atmospheric production of H2SO4 and NH3

The hydrolysis of sulfonylamine (HNSO₂) results in the formation of sulfuric acid along with ammonia, and is of significant interest due to their negative impact on environment and life on Earth. The formation of H₂SO₄ through the reaction of HNSO₂ with (H₂O)_2-4 has been studied using high level electronic structure calculations. This hydrolysis reaction is a step-wise process, in the first step a H-atom from H₂O is transferred to the N-atom of HNSO₂ which results in the formation of NH₂, and in the next step, H₂SO₄, NH₃ and water molecule(s) are formed. The results show that the energy barrier associated with the formation of intermediates and product complexes is reduced by 7 to 10 kcal/mol when the number of water molecules is increased from 2 to 4. The rate constant was calculated using canonical variational transition state theory with small curvature tunneling correction over the temperature range of 200 to 1000 K. At 298 K, the calculated rate constant for the formation of intermediate in the first step is 2.24 × 10⁻¹⁶, 1.03 × 10⁻¹², and 2.10 × 10⁻¹¹ cm³ mol⁻¹ s⁻¹, respectively, for the reaction with water dimer, trimer and tetramer. The calculated enthalpy and free energy show that the reaction corresponding to the formation of H₂SO₄ is highly exothermic and exoergic in nature.     

科研转化的综合化学实验:银纳米粒子的制备及其催化反应动力学测量

设计了一个包含胶体化学方法制备金属纳米粒子及其作为异相催化剂催化氧化还原反应的动力学过程等内容的本科生综合化学实验。首先采用晶种生长法合成了不同尺寸的球状和片状银纳米粒子,然后经过离心纯化后作为异相催化剂催化硼氢化钠还原4-硝基苯酚的反应,研究了催化反应动力学过程,分析了催化反应的表观反应速率常数和催化剂的活性。本实验可以锻炼学生制备纳米材料和跟踪反应动力学进程的能力,使学生进一步理解异相催化反应机理、熟悉光谱仪器的应用。     

富马酸丙酚替诺福韦合成工艺改进

对富马酸丙酚替诺福韦的合成工艺进行了改进,以干燥的替诺福韦为起始原料,与亚磷酸三苯酯反应得到(R)-9-(2-(苯基磷酰基甲氧基)丙基)腺嘌呤（3）; 3被氯化亚砜氯代得(R)-9-(2-(((苯基)(氯代)(磷酰基)甲氧基)丙基)腺嘌呤（4）; 4与L-丙氨酸异丙酯盐酸盐缩合得9-((R)-2-(((S)-((1-(异丙氧基羰基)乙基)氨基)苯氧基磷酰基)甲氧基)丙基)腺嘌呤（5）; 5经析晶纯化得9-((R)-2-(((S)-（((S)-1-(异丙氧基羰基)乙基)氨基)苯氧基磷酰基)甲氧基)丙基)腺嘌呤（丙酚替诺福韦,6）; 6与富马酸成盐得富马酸丙酚替诺福韦,其结构经¹H NMR, ¹³C NMR, MS(ESI),元素分析和XRD确证。按改进工艺进行公斤级规模放大,产品总收率达到32.2%,化学纯度99.92%,非对映异构体纯度99.99%。     

脱氢氨基酸的合成及其在药物研发中的应用

传统多肽所具有的容易被酶解、细胞膜通透性差以及构象容易发生变化等缺点,限制了它作为药物在疾病治疗领域的应用。将脱氢氨基酸引入多肽,对其进行构象限制,能够有效改善它的代谢稳定性和生物利用度。本文主要综述了α,β-脱氢-α-氨基酸、β,γ-脱氢-α-氨基酸、α-脱氢-β-氨基酸、α,β-脱氢-β-氨基酸四种脱氢氨基酸的合成方法以及近几年来在药物设计中的应用,希望为相关的研究提供参考。